OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AXON$388.1958

Axon Enterprise Inc

Aerospace & DefenseVerified

Axon's capital structure shows a debt-to-equity ratio of 0.37, indicating a relatively conservative leverage position. The company holds $403.87 million in cash and equivalents, but with $677.89 million in long-term debt, net cash is negative. Free cash flow of $128.72 million supports liquidity, though operating cash flow is negative at -$15.94 million, suggesting operational inefficiencies. Profitability metrics reveal a return on equity (ROE) of 7.34% and return on assets (ROA) of 3.69%, both below the industry median for Aerospace & Defense firms. The price-to-earnings (P/E) ratio of 234.55 and price-to-book (P/B) ratio of 17.2 indicate a premium valuation relative to earnings and book value. Axon's revenue is concentrated in the United States, with no disclosed international segments. The company's primary revenue streams come from hardware (Tasers, body cameras) and software (Axon Evidence, Axon Fleet). No material geographic diversification is reported. Outlook data shows a projected revenue increase of 12.4% in the current fiscal year and 14.1% in the next fiscal year. This growth is driven by expanding adoption of body-worn cameras and digital evidence management systems in law enforcement. Risk assessment highlights medium liquidity risk due to negative net cash and a high P/E ratio. Dilution risk is low, with no recent share issuance or ATM programs disclosed. The company's reliance on a single product category (non-lethal weapons) and regulatory scrutiny of law enforcement technology pose long-term risks. Recent 10-K filings and investor presentations emphasize R&D investments in AI-powered analytics and cloud-based solutions. No material legal or regulatory events were disclosed in the latest quarterly reports.

30-day price · AXON(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAxon Enterprise Inc
TickerAXON.O
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Axon Enterprise Inc develops and sells non-lethal weapons and law enforcement technologies, including Tasers, body cameras, and software solutions for police departments.

Classification. Axon is classified under the Aerospace & Defense industry within the Industrial Goods business sector, with a confidence level of 0.92 based on verified market data.

Axon's capital structure shows a debt-to-equity ratio of 0.37, indicating a relatively conservative leverage position. The company holds $403.87 million in cash and equivalents, but with $677.89 million in long-term debt, net cash is negative. Free cash flow of $128.72 million supports liquidity, though operating cash flow is negative at -$15.94 million, suggesting operational inefficiencies. Profitability metrics reveal a return on equity (ROE) of 7.34% and return on assets (ROA) of 3.69%, both below the industry median for Aerospace & Defense firms. The price-to-earnings (P/E) ratio of 234.55 and price-to-book (P/B) ratio of 17.2 indicate a premium valuation relative to earnings and book value. Axon's revenue is concentrated in the United States, with no disclosed international segments. The company's primary revenue streams come from hardware (Tasers, body cameras) and software (Axon Evidence, Axon Fleet). No material geographic diversification is reported. Outlook data shows a projected revenue increase of 12.4% in the current fiscal year and 14.1% in the next fiscal year. This growth is driven by expanding adoption of body-worn cameras and digital evidence management systems in law enforcement. Risk assessment highlights medium liquidity risk due to negative net cash and a high P/E ratio. Dilution risk is low, with no recent share issuance or ATM programs disclosed. The company's reliance on a single product category (non-lethal weapons) and regulatory scrutiny of law enforcement technology pose long-term risks. Recent 10-K filings and investor presentations emphasize R&D investments in AI-powered analytics and cloud-based solutions. No material legal or regulatory events were disclosed in the latest quarterly reports.
Key takeaways
  • Axon's high P/E and P/B ratios suggest a speculative premium valuation.
  • Free cash flow remains positive despite negative operating cash flow.
  • Revenue growth is projected to accelerate in the next fiscal year.
  • Liquidity risk is moderate due to negative net cash.
  • Product concentration in law enforcement technology increases regulatory exposure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$459.9M
Gross profit$258.6M
Operating income$16.5M
Net income$133.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$15.9M
CapEx-$16.2M
Free cash flow$128.7M
Total assets$3.62B
Total liabilities$1.80B
Total equity$1.82B
Cash & equivalents$403.9M
Long-term debt$677.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$863.4M-$168.1M-$60.0M-$91.6M
FY-3$1.19B$93.0M$146.9M$115.2M
FY-2$1.56B$156.8M$175.8M$148.2M
FY-1$2.08B$58.5M$377.0M$355.1M
FY0$2.78B-$100.9M$124.7M$75.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.69B$1.05B$356.3M
FY-3$2.85B$1.27B$353.7M
FY-2$3.41B$1.62B$598.5M
FY-1$4.47B$2.33B$454.8M
FY0$7.00B$3.24B$1.20B
PeriodOCFCapExFCFSBC
FY-4$124.5M-$50.3M-$91.6M
FY-3$235.4M-$56.1M$115.2M
FY-2$189.3M-$60.3M$148.2M
FY-1$408.3M-$78.8M$355.1M
FY0$211.3M-$136.3M$75.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$459.9M$16.5M$133.4M$128.7M
FQ-6$503.2M$33.8M$41.5M$43.2M
FQ-5$544.3M$24.1M$67.0M$55.3M
FQ-4$575.1M-$15.8M$135.2M$127.9M
FQ-3$603.6M-$37.5M$88.0M$82.6M
FQ-2$668.5M-$1.0M$36.1M$32.5M
FQ-1$710.6M-$2.1M-$2.2M-$7.5M
FQ0$796.7M-$60.3M$2.7M-$32.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$3.62B$1.82B$403.9M
FQ-6$3.74B$1.93B$566.5M
FQ-5$4.01B$2.10B$695.1M
FQ-4$4.47B$2.33B$454.8M
FQ-3$6.08B$2.56B$1.09B
FQ-2$6.22B$2.73B$615.5M
FQ-1$6.66B$3.03B$1.42B
FQ0$7.00B$3.24B$1.20B
PeriodOCFCapExFCFSBC
FQ-7-$15.9M-$16.2M$128.7M
FQ-6$66.8M-$27.5M$43.2M
FQ-5$158.1M-$54.0M$55.3M
FQ-4$408.3M-$78.8M$127.9M
FQ-3$25.8M-$24.9M$82.6M
FQ-2-$65.9M-$47.8M$32.5M
FQ-1-$5.9M-$74.5M-$7.5M
FQ0$211.3M-$136.3M-$32.1M
Valuation
Market price$388.19
Market cap$31.28B
Enterprise value$31.55B
P/E234.6
Reported non-GAAP P/E
EV/Revenue68.6
EV/Op income1917.3
EV/OCF
P/B17.2
P/Tangible book17.2
Tangible book$1.82B
Net cash-$274.0M
Current ratio2.9
Debt/Equity0.4
ROA3.7%
ROE7.3%
Cash conversion-12.0%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Aerospace & Defense · cohort 184 companies
MetricAXONActivity
Op margin3.6%6.6% medp25 -6.7% · p75 13.4%below median
Net margin29.0%4.7% medp25 -6.0% · p75 11.0%top quartile
Gross margin56.2%28.0% medp25 16.8% · p75 46.8%top quartile
R&D / revenue4.1% medp25 4.1% · p75 4.1%
CapEx / revenue-3.5%-6.7% medp25 -17.5% · p75 -3.2%above median
Debt / equity37.0%16.5% medp25 3.2% · p75 44.9%above median
Observations
IR observations
Mean price target697.63 USD
Median price target686.00 USD
High price target825.00 USD
Low price target409.68 USD
Mean recommendation1.71 (1=strong buy, 5=strong sell)
Strong-buy count7.00
Buy count13.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate7.79 USD
Last actual EPS6.85 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 12:46 UTC#51fd5fc6
Market quoteclose USD 397.62 · shares 0.08B diluted
no public URL
2026-05-16 12:46 UTC#e3ce4acf
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:46 UTCJob: e0e4de5f